戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  plasmid identified in a clinical isolate of Enterococcus faecium.
2 coccus aureus, Streptococcus pneumoniae, and Enterococcus faecium.
3 trols expression of vancomycin resistance in Enterococcus faecium.
4 e of 24% and all isolates were identified as Enterococcus faecium.
5 ncoding VanB-type glycopeptide resistance in Enterococcus faecium.
6  patients were Clostridium sp. 7 2 43FAA and Enterococcus faecium.
7 gene fusion is regulated by VanR and VanS of Enterococcus faecium.
8 ent bacteremia as a result of infection with Enterococcus faecium.
9 of the bacteria such as Escherichia coli and Enterococcus faecium.
10 idermidis in synthetic urine also containing Enterococcus faecium.
11 aphylococcus aureus and vancomycin-resistant Enterococcus faecium.
12 s Lactococcus casei, Lactococcus lactis, and Enterococcus faecium.
13  neonate colonized with vancomycin-resistant Enterococcus faecium.
14 aphylococcus aureus and vancomycin-resistant Enterococcus faecium.
15 rmediate S. aureus, and vancomycin-resistant Enterococcus faecium.
16 s aureas and vancomycin-resistant strains of Enterococcus faecium.
17 requently precedes invasive infection due to Enterococcus faecium.
18 isolated from 29 cultures, all of which were Enterococcus faecium.
19  has been identified in nonstool isolates of Enterococcus faecium.
20 due to rESKAPE strains (vancomycin-resistant Enterococcus faecium [0], methicillin-resistant Staphylo
21 cocci (16.9%), Escherichia coli (11.8%), and Enterococcus faecium (11.4%).
22                 Enterococcus faecalis (48%), Enterococcus faecium (14%), Enterococcus mundtii (13%),
23 ates of Enterococcus faecalis, 8 isolates of Enterococcus faecium, 2 isolates of Enterococcus hirae,
24 single-patient VRE isolates that included 83 Enterococcus faecium, 33 E. gallinarum, and 5 E. casseli
25 us faecalis (87/91 isolates and ATCC 19433), Enterococcus faecium (5/13 isolates), Enterococcus casse
26                                              Enterococcus faecium 664.1H1 is multiply antibiotic resi
27 hich contain the vancomycin-binding site) in Enterococcus faecium, a leading antibiotic-resistant pat
28 etyltransferases are nanomolar inhibitors of Enterococcus faecium AAC(6')-Ii.
29 ined individually and in combination against Enterococcus faecium, Acinetobacter baumannii and Klebsi
30                A collagen-binding adhesin of Enterococcus faecium, Acm, was identified.
31 rcent of bacteria were MDR, including 95% of Enterococcus faecium and 55% of Enterobacteriaceae; 82%
32 , Bacteroides fragilis, and a combination of Enterococcus faecium and Bacteroides distasonis.
33 cover and differentiate vancomycin-resistant Enterococcus faecium and Enterococcus faecalis (VRE).
34 al for high-level glycopeptide resistance in Enterococcus faecium and Enterococcus faecalis by synthe
35 aphylococcus epidermidis and vanA or vanB in Enterococcus faecium and Enterococcus faecalis) by the B
36  bacteria, including human pathogens such as Enterococcus faecium and Listeria monocytogenes.
37 ia (high priority) were vancomycin-resistant Enterococcus faecium and meticillin-resistant Staphyloco
38            With the exception of 2 isolates, Enterococcus faecium and Nocardia exalbida, all the othe
39 drug-sensitive and drug-resistant strains of Enterococcus faecium and Staphylococcus aureus.
40 vast majority of E. faecalis strains (unlike Enterococcus faecium and streptococci) have a single pil
41   The VRE type A strain was a vanA strain of Enterococcus faecium and was highly resistant to all ant
42 occus pneumoniae, Enterococcus faecalis, and Enterococcus faecium) and three associated genetic resis
43 ptomycin versus 48 Enterococcus faecalis, 51 Enterococcus faecium, and 50 Staphylococcus aureus isola
44  Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and beta-lactam-resistant Klebsiel
45 single polypeptide in Enterococcus faecalis, Enterococcus faecium, and Enterococcus hirae.
46  aureus, high-level vancomycin resistance in Enterococcus faecium, and resistance to extended-spectru
47 that the silver/platinum combination against Enterococcus faecium, and silver/copper combination agai
48 ted and dispersed MRSA, vancomycin-resistant Enterococcus faecium, and Staphylococcus epidermidis bio
49  in the cell walls of vancomycin-susceptible Enterococcus faecium (ATTC 49624).
50 ied 14/15 cases of Enterococcus faecalis and Enterococcus faecium bacteremia and 9 cases of Streptoco
51 ront-line antibiotic for multidrug-resistant Enterococcus faecium bloodstream infections (BSIs).
52 level type A and B vancomycin resistances of Enterococcus faecium BM4147 and Ent. faecalis have been
53              d-alanine-d-lactate ligase from Enterococcus faecium BM4147 is directly responsible for
54 igh-level inducible vancomycin resistance in Enterococcus faecium BM4147.
55 sistance has been reported for an isolate of Enterococcus faecium, BM4339.
56 or secreted antigen, SagA, was identified in Enterococcus faecium by screening an E. faecium genomic
57 tion by ampicillin- and vancomycin-resistant Enterococcus faecium C68 in a mouse model.
58 estinal colonization by vancomycin-resistant Enterococcus faecium C68 in a mouse model.
59        The plasmids pHKK702 and pHKK703 from Enterococcus faecium clinical isolate R7 have been impli
60 tide resistance element, Tn1546, in 124 VanA Enterococcus faecium clinical isolates from 13 Michigan
61  serologically related, vancomycin-resistant Enterococcus faecium clinical isolates.
62  87 specimens that were culture positive for Enterococcus faecium containing vanA were positive by PC
63 nd ponA) were deleted from the chromosome of Enterococcus faecium D344R in all possible combinations
64  the excision of a large genomic region from Enterococcus faecium D344R in which the sequence from "j
65 ur in ampicillin-resistant, Tn916-containing Enterococcus faecium D344R.
66 tems of esp-deficient Lactococcus lactis and Enterococcus faecium did not enhance biofilm formation a
67       Here, we identified 2 gene clusters in Enterococcus faecium each encoding a homolog of Gls24 (G
68                                              Enterococcus faecium encodes a triple-specific aaPGS (Ra
69  identification of VanA- and VanB-containing Enterococcus faecium (ENFM) and Enterococcus faecalis (E
70  infections caused by Staphylococcus aureus, Enterococcus faecium, Enterococcus faecalis, Klebsiella
71 nterococci, including Enterococcus faecalis, Enterococcus faecium, Enterococcus gallinaraum, and Ente
72 rophosphate LTAs from Enterococcus faecalis, Enterococcus faecium, Enterococcus hirae, Listeria monoc
73 rast to previously characterized aaPGSs, the Enterococcus faecium enzyme used an expanded repertoire
74                                   Strains of Enterococcus faecium express a cell wall-anchored protei
75 g a predicted fibronectin-binding protein of Enterococcus faecium (fnm), a homologue of Streptococcus
76 s in tissues of morphine-withdrawn mice were Enterococcus faecium followed by Klebsiella pneumoniae.
77 pplemental testing of ampicillin-susceptible Enterococcus faecium for motility and the ability to aci
78 mained febrile and grew vancomycin-resistant Enterococcus faecium from the cerebrospinal fluid.
79                                          The Enterococcus faecium genogroup, referred to as clonal co
80  nosocomial isolation of multidrug-resistant Enterococcus faecium has dramatically reduced the therap
81                                              Enterococcus faecium has recently emerged as a serious n
82                                              Enterococcus faecium has recently emerged as an importan
83         The incidence of multidrug-resistant Enterococcus faecium hospital infections has been steadi
84 rted to be important for the pathogenesis of Enterococcus faecium in a rat infective endocarditis mod
85                    Enterococcus faecalis and Enterococcus faecium infections are increasingly difficu
86          In particular, vancomycin-resistant Enterococcus faecium infections have been increasing in
87 y tract infections; and vancomycin-resistant Enterococcus faecium infections, including cases with co
88 99 for the treatment of vancomycin-resistant Enterococcus faecium infections.
89                                              Enterococcus faecium is a common cause of nosocomial inf
90 lthough the opportunistic bacterial pathogen Enterococcus faecium is a leading source of nosocomial i
91                                              Enterococcus faecium is a multidrug-resistant opportunis
92                                              Enterococcus faecium is an important cause of hospital-a
93 nical settings, non-susceptibility to DAP by Enterococcus faecium is correlated frequently with a mut
94  We show that secreted antigen A (SagA) from Enterococcus faecium is sufficient to protect Caenorhabd
95 estinal colonization by antibiotic-resistant Enterococcus faecium is the first step in a process that
96  report of vancomycin heteroresistance in an Enterococcus faecium isolate from a patient.
97       Enterococcus faecalis (50) outnumbered Enterococcus faecium isolates (18), and 49% of enterococ
98 containing SmaI restriction patterns from 62 Enterococcus faecium isolates and the other containing S
99  clinical isolates of glycopeptide-resistant Enterococcus faecium isolates collected from hospitals i
100 e streptogramin quinupristin-dalfopristin in Enterococcus faecium isolates from chickens on the Easte
101 us, 90% of Enterococcus faecalis, and 88% of Enterococcus faecium isolates were interpreted as suscep
102                All Enterococcus faecalis and Enterococcus faecium isolates were observed to be nonmot
103 inezolid-resistant Enterococcus faecalis and Enterococcus faecium isolates with a G2576U rRNA mutatio
104                  The increasing frequency of Enterococcus faecium isolates with multidrug resistance
105 he E. faecalis isolates and six (23%) of the Enterococcus faecium isolates.
106 E are present in most E. faecalis but not in Enterococcus faecium isolates.
107 eus, Bacillus cereus, Enterococcus faecalis, Enterococcus faecium, Listeria monocytogenes, Streptococ
108 of linezolid-resistant, vancomycin-resistant Enterococcus faecium (LRVRE).
109  Enterococcus faecalis (green colonies) from Enterococcus faecium (mauve colonies) on the basis of ch
110  as antibiotics against vancomycin-resistant Enterococcus faecium, methicillin-resistant Staphylococc
111 +/- 0.4 microg/mL), and vancomycin-resistant Enterococcus faecium (MIC(50) 2.9 +/- 0.8 microg/mL).
112             The high-level-resistant strain (Enterococcus faecium; MIC, 512 microg/ml) was accurately
113 stream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration,
114                    Isolated species included Enterococcus faecium (n = 13), Enterococcus faecalis (n
115 esistant Staphylococcus aureus (n = 14), and Enterococcus faecium (n = 14).
116 ine and linezolid were highly active against Enterococcus faecium (n = 267) globally (100% and 98% su
117 ee important pathogens: vancomycin-resistant Enterococcus faecium (n=19), methicillin-resistant Staph
118 n of the vanA gene in 81 cultures containing Enterococcus faecium or E. faecalis was 100% sensitive a
119  The four patients presented here had either Enterococcus faecium or Enterococcus faecalis bacteremia
120 ated colonies as either vancomycin-resistant Enterococcus faecium or Enterococcus faecalis, based on
121 ylococcus aureus, but not Bacillus subtilis, Enterococcus faecium, or Streptococcus pyogenes, kill ad
122                                              Enterococcus faecium organisms (MIC, > 256 micrograms/ml
123 ation demonstrated platinum and gold against Enterococcus faecium, platinum against Klebsiella pneumo
124         Here, we identify and characterize 6 Enterococcus faecium proteins containing the WxL domain
125 ne quinupristin-dalfopristin (Q-D)-resistant Enterococcus faecium (QDREF) isolates were isolated from
126                                              Enterococcus faecium recently evolved from a generally a
127                 The past few years have seen Enterococcus faecium resistance to vancomycin increase f
128                We have shown previously that Enterococcus faecium SagA has broad-spectrum binding to
129 enterococcal isolates were tested, including Enterococcus faecium (six isolates), Enterococcus faecal
130    Human epidemic clones ( E. coli ST131 and Enterococcus faecium ST17) were identified for the first
131 ptococcus pneumoniae, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, and Klebsie
132                                              Enterococcus faecium strain 9631355 was isolated from an
133            One-on-one comparisons of 10 vanA Enterococcus faecium strain types all yielded > 10 band
134                                           An Enterococcus faecium strain with high-level resistance t
135 re induced in one Campylobacter coli and one Enterococcus faecium strain, while these strains plus th
136 of patients were infected with the same vanB Enterococcus faecium strain.
137 lled two (28%) of seven vancomycin-resistant Enterococcus faecium strains.
138 ridans streptococcus, Enterococcus faecalis, Enterococcus faecium, Streptococcus agalactiae, Escheric
139 quired resistance of the nosocomial pathogen Enterococcus faecium to the group A component of natural
140                              For one strain (Enterococcus faecium U8304), the ability of GPS to detec
141 ococcus pneumoniae (6), vancomycin-resistant Enterococcus faecium (VRE FCM) (16), vancomycin-suscepti
142 rointestinal tract with vancomycin-resistant Enterococcus faecium (VRE) has become endemic in many ho
143        A mouse model of vancomycin-resistant Enterococcus faecium (VRE) intestinal colonization was u
144 c DNA extracted from 45 vancomycin-resistant Enterococcus faecium (VRE) isolates was cleaved with Hin
145 ical data for typing 45 vancomycin-resistant Enterococcus faecium (VRE) isolates.
146  Thirty-two isolates of vancomycin-resistant Enterococcus faecium (VRE) recovered from 25 patients ho
147 lococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), and beta-lactam-resistant Kl
148 lococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), Escherichia coli SMS-3-5, an
149 te the dissemination of vancomycin-resistant Enterococcus faecium (VREF) in a 728-bed tertiary-care h
150                         Vancomycin-resistant Enterococcus faecium (VREF) was isolated from six pigs b
151 occus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) with MIC values of 1.4 and 2
152 occus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF).
153                         Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of nosoc
154                         Vancomycin-resistant Enterococcus faecium (VREfm) is an important cause of he
155 ncomycin-resistant Enterococcus faecalis and Enterococcus faecium, VRESelect, was compared to bile es
156 o-component signal transduction pathway from Enterococcus faecium was reconstituted in vitro from par
157 precedes infection with antibiotic-resistant Enterococcus faecium We used a mouse GIT colonization mo
158             When 10(3) or 10(6) cfu/mL of VR Enterococcus faecium were added to the CFCE culture, the
159 ates of E. faecalis and 24 blood isolates of Enterococcus faecium were compared.
160 cocci [IVRE]) from Enterococcus faecalis and Enterococcus faecium were evaluated.
161     Virginiamycin use in poultry selects for Enterococcus faecium with cross-resistance to quinuprist
162  experimental endocarditis using a strain of Enterococcus faecium with high-level resistance to vanco
163 ly, pretreatment of Staphylococcus aureus or Enterococcus faecium with subinhibitory doses of beta-la
164                              Two isolates of Enterococcus faecium with VanA glycopeptide resistance w
165  experiments to investigate the transport of Enterococcus faecium within saturated quartz sands.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top